Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma

J. Bohosova, A. Kubickova, O. Slaby

. 2021 ; 11 (5) : . [pub] 20210429

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025824

Grantová podpora
NV18-03-00554 Ministerstvo Zdravotnictví Ceské Republiky

LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors outlines the essential role of PVT1 in the development of RCC. There is already a plethora of publications trying to uncover the cellular mechanisms of PVT1-mediated regulation and its potential exploitation in management of RCC. In this review, we summarize the literature focused on PVT1 in RCC and aim to synthesize the current knowledge on its role in the cells of the kidney. Further, we provide an overview of the lncRNA profiling studies that have identified a more or less significant association of PVT1 with the clinical behavior of RCC. Based on our search, we analyzed the 17 scientific papers discussed in this review that provide robust support for the indispensable role of PVT1 in RCC development and future personalized therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025824
003      
CZ-PrNML
005      
20211026133451.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom11050664 $2 doi
035    __
$a (PubMed)33947142
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bohosova, Julia $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic
245    10
$a lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma / $c J. Bohosova, A. Kubickova, O. Slaby
520    9_
$a LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors outlines the essential role of PVT1 in the development of RCC. There is already a plethora of publications trying to uncover the cellular mechanisms of PVT1-mediated regulation and its potential exploitation in management of RCC. In this review, we summarize the literature focused on PVT1 in RCC and aim to synthesize the current knowledge on its role in the cells of the kidney. Further, we provide an overview of the lncRNA profiling studies that have identified a more or less significant association of PVT1 with the clinical behavior of RCC. Based on our search, we analyzed the 17 scientific papers discussed in this review that provide robust support for the indispensable role of PVT1 in RCC development and future personalized therapy.
650    _2
$a karcinom z renálních buněk $x genetika $7 D002292
650    _2
$a pohyb buněk $7 D002465
650    _2
$a proliferace buněk $7 D049109
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a nádory ledvin $x genetika $7 D007680
650    _2
$a prognóza $7 D011379
650    _2
$a RNA dlouhá nekódující $x genetika $7 D062085
650    _2
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kubickova, Adela $u Department of Pharmacology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 5 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33947142 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133457 $b ABA008
999    __
$a ok $b bmc $g 1714743 $s 1146331
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 5 $e 20210429 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
GRA    __
$a NV18-03-00554 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace